Kerri A. Johannson

Employment

• University of Calgary Associate Professor

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (74)

• Breathlessness in Fibrotic Hypersensitivity Pneumonitis: From Symptom to Signal
  Annals of the American Thoracic Society 2026 DOI: 10.1093/annalsats/aaoag241
  +Save
• Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report
  American Journal of Respiratory and Critical Care Medicine 2026 DOI: 10.1093/ajrccm/aamag363
  +Save
• FIBRONEER-ILD: taking a second look at the data
  European Respiratory Journal 2026 DOI: 10.1183/13993003.00623-2026
  +Save
• Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease
  Respiratory Medicine 2026 DOI: 10.1016/j.rmed.2026.108808
  +Save
• An Evidence-Based Exposure Questionnaire for Interstitial Lung Disease: EXPO-ILD
  CHEST Pulmonary 2026 DOI: 10.1016/j.chpulm.2026.100253
  +Save
• Respiratory oscillometry: the new kid on the lung function block
  BMJ Open Respiratory Research 2026 DOI: 10.1136/bmjresp-2026-004119
  +Save
• The impact of pulmonary fibrosis on sex and sexual function: a multinational mixed methods study
  European Respiratory Journal 2026 DOI: 10.1183/13993003.01039-2025
  +Save
• Guidelines in context: Adapting the American Thoracic Society interstitial lung abnormalities clinical statement to Canadian practice
  Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2026 DOI: 10.1080/24745332.2026.2704190
  +Save
• Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease
  American Journal of Respiratory and Critical Care Medicine 2025 DOI: 10.1164/rccm.202407-1504OC
  +Save
• Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis
  European Respiratory Journal 2025 DOI: 10.1183/13993003.01575-2024
  +Save